title: Reversible Posterior Leukoencephalopathy Syndrome after Eribulin Mesylate Chemotherapy for Breast Cancer.
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Young Mi
authors.initials: YM
authors.lastname: Seol
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Do Young
authors.initials: DY
authors.lastname: Kim
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Hyo Jeong
authors.initials: HJ
authors.lastname: Kim
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Young Jin
authors.initials: YJ
authors.lastname: Choi
mesh_terms: D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D006801:Humans; D054038:Posterior Leukoencephalopathy Syndrome
chemical_list: D000970:Antineoplastic Agents